Adaptation of the cellscan technique for the SCM test in breast cancer

H. Rahmani, M. Deutsch*, I. Ron, S. Gerbat, R. Tirosh, A. Weinreb, S. Chaitchik, S. Lalchuk

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The value of the SCM (Structuredness of Cytoplasmic Matrix) cancer test, a procedure based on the detection of differences in lymphocyte activation in the presence and absence of cancer, has remained controversial, with inconsistent results having been reported among investigators, The Cellscan, a high-precision static cytometer system, has been designed to perform the SCM test; the apparatus facilitates the polarisation measurements and can examine cells which have been separated by simpler procedures than were originally described. In this study, using methods and diagnostic criteria adapted for the Cellscan system in a hospital environment, the SCM test correctly classified over 90% (76/80) of patients with breast cancer and differentiated over 90% (72/73) of individuals without cancer.

Original languageEnglish
Pages (from-to)1758-1765
Number of pages8
JournalEuropean Journal of Cancer
Volume32
Issue number10
DOIs
StatePublished - Sep 1996

Keywords

  • Cancer detection
  • Fluorescein fluorescence polarisation
  • Immune system
  • Lymphocytes
  • SCM test

Fingerprint

Dive into the research topics of 'Adaptation of the cellscan technique for the SCM test in breast cancer'. Together they form a unique fingerprint.

Cite this